Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seqirus
Age
0–9
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female aged \>= 6 months to \< 9 years at the time of the first study vaccination.
For children \< 3 years of age at the time of first vaccination, born at or after 36 weeks gestation.
You may not be if
Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, neomycin, polymyxin, or any components of the Study Vaccine
Clareo Health | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA
